Results for tag: "Oxtellar"

The Oxtellar market is a subset of the Central Nervous System (CNS) drugs market. It is composed of drugs used to treat epilepsy, a neurological disorder characterized by recurrent seizures. Oxtellar is a brand name for oxcarbazepine, an anticonvulsant drug used to treat partial seizures in adults and children over the age of 6. Oxtellar is also used to treat bipolar disorder, a mental health condition characterized by extreme shifts in mood. The Oxtellar market is highly competitive, with several major pharmaceutical companies vying for market share. Companies in the market include Novartis, Sun Pharmaceuticals, Mylan, and Teva Pharmaceuticals. Other companies, such as Dr. Reddy's Laboratories, Lupin, and Torrent Pharmaceuticals, also offer generic versions of Oxtellar. Show Less Read more